Logo image of IPR.LS

IMPRESA SGPS SA (IPR.LS) Stock Fundamental Analysis

ELI:IPR - Euronext Lisbon - PTIPR0AM0000 - Common Stock - Currency: EUR

0.1215  0 (-0.82%)

Fundamental Rating

0

Taking everything into account, IPR scores 0 out of 10 in our fundamental rating. IPR was compared to 62 industry peers in the Media industry. Both the profitability and financial health of IPR have multiple concerns. IPR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IPR had negative earnings in the past year.
In the past year IPR had a positive cash flow from operations.
In multiple years IPR reported negative net income over the last 5 years.
Each year in the past 5 years IPR had a positive operating cash flow.
IPR.LS Yearly Net Income VS EBIT VS OCF VS FCFIPR.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

With a Return On Assets value of -19.48%, IPR is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -73.96%, IPR is doing worse than 82.54% of the companies in the same industry.
Industry RankSector Rank
ROA -19.48%
ROE -73.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPR.LS Yearly ROA, ROE, ROICIPR.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

IPR has a worse Gross Margin (33.52%) than 71.43% of its industry peers.
In the last couple of years the Gross Margin of IPR has declined.
The Profit Margin and Operating Margin are not available for IPR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.81%
GM growth 5Y-10.84%
IPR.LS Yearly Profit, Operating, Gross MarginsIPR.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

IPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
IPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IPR.LS Yearly Shares OutstandingIPR.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
IPR.LS Yearly Total Debt VS Total AssetsIPR.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -0.29, we must say that IPR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IPR (-0.29) is worse than 77.78% of its industry peers.
IPR has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
IPR's Debt to Equity ratio of 1.16 is on the low side compared to the rest of the industry. IPR is outperformed by 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACCN/A
WACC7.66%
IPR.LS Yearly LT Debt VS Equity VS FCFIPR.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

IPR has a Current Ratio of 0.53. This is a bad value and indicates that IPR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.53, IPR is doing worse than 88.89% of the companies in the same industry.
IPR has a Quick Ratio of 0.53. This is a bad value and indicates that IPR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.52, IPR is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.52
IPR.LS Yearly Current Assets VS Current LiabilitesIPR.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for IPR have decreased strongly by -3333.91% in the last year.
Looking at the last year, IPR shows a decrease in Revenue. The Revenue has decreased by -2.25% in the last year.
Measured over the past years, IPR shows a decrease in Revenue. The Revenue has been decreasing by -0.34% on average per year.
EPS 1Y (TTM)-3333.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3068.8%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y-2.2%
Revenue growth 5Y-0.34%
Sales Q2Q%-5.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPR.LS Yearly Revenue VS EstimatesIPR.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IPR.LS Yearly EPS VS EstimatesIPR.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0.02 0.04 0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPR.LS Price Earnings VS Forward Price EarningsIPR.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPR.LS Per share dataIPR.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMPRESA SGPS SA

ELI:IPR (8/8/2025, 7:00:00 PM)

0.1215

0 (-0.82%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-24 2025-07-24
Earnings (Next)N/A N/A
Inst Owners1.78%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap20.41M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF 11.46
P/B 0.23
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0.01
OCFY8.72%
SpS1.05
BVpS0.53
TBVpS-0.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.48%
ROE -73.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.52%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.81%
GM growth 5Y-10.84%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.52
Altman-Z -0.29
F-Score4
WACC7.66%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3333.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3068.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y-2.2%
Revenue growth 5Y-0.34%
Sales Q2Q%-5.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-578.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-100.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.24%
OCF growth 3Y-57.59%
OCF growth 5Y-39.33%